CATEGORIES

Pharmaceutics

LATEST

TRENDING

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

First Drug Synthesized by AI Goes into Clinical Trials

If all goes well, thanks to artificial intelligence, we may soon have a new AI-synthesized drug capable of assisting OCD patients in managing their symptoms and thus leading normal lives.

The Covid Global Clinical Trials for mRNA. Thank You for Participating

There are more than one hundred ways an RNA molecule can be chemically modified after it is synthesized. The functions of many of these...

Perrigo Voluntarily Recalls Albuterol Sulfate Inhalation Aerosol

A voluntary U.S. nationwide recall of albuterol sulfate inhalation aerosol to the retail level after previously halting production and distribution.